| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/28/1992 | US5108757 Sustained release of nifedipine |
| 04/28/1992 | US5108756 Controlled delivery of one or more beneficial agents |
| 04/28/1992 | US5108754 Orthomolecular method of treating sickle cell disease |
| 04/28/1992 | US5108753 Osteogenic devices |
| 04/28/1992 | US5108710 Consistently exposes to leaching liquid |
| 04/28/1992 | US5108636 Magnetizable composite particles based on crosslinked organopolysiloxane, process for preparation thereof and their application in biology |
| 04/28/1992 | CA1299583C Effervescent couples, histamine h -antagonist effervescent compositions containing them and their preparation |
| 04/28/1992 | CA1299581C Cosmetic composition containing chalcone hydroxylated derivatives and usethereof for the protection of skin and hair against light irradiation, novel chalcones used and preparation process thereof |
| 04/27/1992 | WO1992007554A1 Implantable biodegradable material and method for producing same |
| 04/25/1992 | CA2054017A1 Antidiarrheal compositions |
| 04/23/1992 | WO1992006709A1 Lipid a composition as immunogenic agents to prevent or treat gram-negative bacterial infections |
| 04/23/1992 | WO1992006672A1 Encapsulated antiperspirant salts and deodorant/antiperspirants |
| 04/23/1992 | DE4033524A1 1-(Tert.-butylamino)-3-((6-chloro-m-tolyl)-oxy)-2-propanol - for transdermal use to reduce total cholesterol content and for treatment of atherosclerosis |
| 04/23/1992 | DE4033445A1 Pour-on formulation against endo-parasites for dogs and cats - comprises levamisole or tetramisole in N-methyl:pyrrolidine, has good penetration without damage to skin |
| 04/23/1992 | DE4032096A1 Emulsifier-free emulsion polymers for pharmaceuticapreparations |
| 04/23/1992 | CA2094588A1 Lipid a composition as immunogenic agents to prevent or treat gram-negative bacterial infections |
| 04/23/1992 | CA2053462A1 Sticky composition for medical use |
| 04/22/1992 | EP0481968A2 Integrated drug dosage form and metering system |
| 04/22/1992 | EP0481939A2 Twin patch applicator |
| 04/22/1992 | EP0481732A1 Prolonged release preparation and polymers thereof |
| 04/22/1992 | EP0481725A1 Piroxicam containing cream |
| 04/22/1992 | EP0481701A1 Treatment composition |
| 04/22/1992 | EP0481675A2 Preparation of medicaments for treating asthma using (S)-alpha-fluoromethyl histidine and esters thereof |
| 04/22/1992 | EP0481600A2 Materials useful in human and veterinary medicine |
| 04/22/1992 | EP0481443A1 Transdermal therapeutic compositions |
| 04/22/1992 | EP0481396A2 Tannin extract of sweet chestnut wood, a process for the preparation thereof and its use |
| 04/22/1992 | EP0481294A1 Solid fast-dissolving pharmaceutical preparation containing S-(carboxymethyl)-L-cysteine and/or N-acetyl-cysteine |
| 04/22/1992 | EP0481240A2 Galactomannan derivate for the encapsulation or incorporation of drugs |
| 04/22/1992 | EP0481226A1 Process for manufacturing water absorption material based on polymer and its use |
| 04/22/1992 | EP0481070A1 Multimeric gelsolin fusion constructs |
| 04/22/1992 | EP0481042A1 Amphoteric hydrogel for medical devices. |
| 04/22/1992 | EP0480983A1 Use of peroxidated lipids for the preparation of medication to be used in the treatment, by local application, of circulation deficiencies. |
| 04/22/1992 | EP0480925A1 Fluorocarbon emulsions having saturated phospholipid emulsifiers. |
| 04/22/1992 | CN1016346B Destructurized starch containing electrolyte |
| 04/21/1992 | US5106627 For controlled delivery of encapsulated neurotransmitter to brain; growth factor source |
| 04/21/1992 | US5106625 Transparent, extendible, adhesive, retentive |
| 04/21/1992 | US5106615 Eyedrops having non-newtonian rheological properties |
| 04/21/1992 | CA1299304C Process for preparing silicone microparticles cured by a michael addition reaction |
| 04/21/1992 | CA1299106C Buccal formulation |
| 04/21/1992 | CA1299105C Buccal formulation |
| 04/21/1992 | CA1299098C Alcohol-based antimicrobial compositions |
| 04/20/1992 | CA2053721A1 Antiphlogistic analgesic cream composition |
| 04/19/1992 | WO1992006995A1 Preparation and characterization of liposomal formulations of tumor necrosis factor |
| 04/19/1992 | WO1992006675A1 Aerosol formulation comprising beclomethasone 17,21 dipropionate |
| 04/19/1992 | CA2091771A1 Preparation and characterization of liposomal formulations of tumor necrosis factor |
| 04/19/1992 | CA2053569A1 Galactomannan derivatives for coating or embedding medicinally active susbstances |
| 04/19/1992 | CA2037536A1 Twin patch applicator |
| 04/18/1992 | WO1992006703A1 Synthetic lung surfactant |
| 04/17/1992 | WO1992006726A1 Vitamin-mineral treatment methods and compositions |
| 04/17/1992 | CA2052855A1 Materials useful in human and veterinary medicine |
| 04/16/1992 | WO1992005781A1 Composition containing ephedrine base and alkyl salicylate for the delivery of ephedrine base in vapor form |
| 04/16/1992 | WO1992005778A1 Ionically cross-linked polymeric microcapsules |
| 04/16/1992 | WO1992005777A1 Multiple vesicle implantable drug delivery system |
| 04/16/1992 | WO1992005776A1 Lateral edge coated controlled release pharmaceutical compositions |
| 04/16/1992 | WO1992005770A1 Drug delivery vehicles suspended in nonaqueous perfluorinated carrier |
| 04/16/1992 | WO1992005766A1 Agents effecting the lysis of oral bacteria |
| 04/16/1992 | DE4031960A1 Herbal compsns. or topical treatment of psoriasis - based on greater celandine |
| 04/15/1992 | EP0480841A1 Disinfactant composition for the agro-alimentary industry and veterinary medicine |
| 04/15/1992 | EP0480729A1 Microencapsulation for controlled oral drug delivery system |
| 04/15/1992 | EP0480690A1 Aqueous ophthalmic microemulsions of tepoxalin |
| 04/15/1992 | EP0480640A1 Lactoneotrehalose, and its preparation and uses |
| 04/15/1992 | EP0480391A2 Emulsion-free emulsion polymers in sustained-release pharmaceutical compositions and their production |
| 04/15/1992 | EP0480054A1 Percutaneously absorbable composition of morphine hydrochloride |
| 04/15/1992 | EP0479781A1 Pharmaceutical composition containing a hydrophilic active compound treated by an organic acid and encapsulated in a liposome. |
| 04/15/1992 | EP0460101A4 Immobilized cytokines |
| 04/15/1992 | EP0438483B1 Triglycerides and nutritional composition comprising such triglycerides |
| 04/15/1992 | EP0437524B1 Triglyceride and nutritional composition comprising such triglycerides. |
| 04/15/1992 | EP0437520B1 Triglyceride and nutritional composition comprising such triglyceride |
| 04/15/1992 | EP0437519B1 Triglycerides and nutritional composition comprising such triglycerides. |
| 04/15/1992 | EP0437518B1 Triglycerides and composition comprising such triglycerides |
| 04/15/1992 | EP0247114B1 Lipid containing plastics |
| 04/15/1992 | EP0177605B1 An enzyme composition acting as a digestion promotor on various levels in the alimentary tract, and a method for facilitating digestion |
| 04/15/1992 | CN1060209A Rare-earth magnetic plaster |
| 04/15/1992 | CN1060206A Apparatus of manufacturing hard capsules for medicament use |
| 04/14/1992 | US5104896 Carboplatin composition |
| 04/14/1992 | US5104870 Psychological disorders |
| 04/14/1992 | US5104787 Method for apparatus for a defined serumfree medical solution useful for corneal preservation |
| 04/14/1992 | US5104736 Reinforced paucilamellar lipid vesicles |
| 04/14/1992 | US5104663 Aqueous acidic Ringer's solution also containing magnesium for mixing with freeze-dried powder containing glutathione; shelf life, surgery |
| 04/14/1992 | US5104662 Intestinal mucous; gelation; lactic acid bacteria |
| 04/14/1992 | US5104661 Diffusion using bipolar lipid; drug delivery |
| 04/14/1992 | US5104657 Combination preparations containing chloramphenicol, gentamicin and nystatin as active ingredients for the topical treatment of inflammatory skin disorders |
| 04/14/1992 | US5104656 Percutaneous treatment with a high potency non-steroidal anti-inflammatory agent |
| 04/14/1992 | US5104655 Or complexes with phospholipids; for topical administration |
| 04/14/1992 | US5104651 Stabilized hydrophobic protein formulations of g-csf |
| 04/14/1992 | US5104648 Blending with binder; spraying, drying |
| 04/14/1992 | US5104546 Pyrogens separations by ceramic ultrafiltration |
| 04/14/1992 | US5104403 Low porosity outer material with inner synthetic tubular mesh; polysaccharides or amino-acid polymers |
| 04/14/1992 | US5103840 Viscoelastic collagen gel for ophthalmic surgery |
| 04/14/1992 | CA1298784C Pharmaceutical formulations with controlled release of the active substance |
| 04/14/1992 | CA1298688C Therapeutic rings |
| 04/13/1992 | WO1992006694A1 Antimicrobial hydrogels |
| 04/13/1992 | CA2092289A1 Antimicrobial hydrogels |
| 04/11/1992 | CA2053005A1 Emulsifier-free emulsion polymers |
| 04/11/1992 | CA2052950A1 Aqueous ophthalmic microemulsions of tepoxalin |
| 04/10/1992 | WO1992006192A1 Inhibition of viral replication |
| 04/10/1992 | WO1992005773A1 Phospholipid analogue vesicle with a succinimidyl moiety |
| 04/10/1992 | CA2093816A1 Inhibition of viral replication |
| 04/10/1992 | CA2093665A1 Phospholipid analogue vesicle |
| 04/09/1992 | WO1992005774A1 Orally administered solvent-free pharmaceutical preparation with delayed active-substance release, and a method of preparing the preparation |